Walgreens Boots Alliance Inc (WBA) : Calamos Wealth Management scooped up 5,907 additional shares in Walgreens Boots Alliance Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 26, 2016. The investment management firm now holds a total of 81,617 shares of Walgreens Boots Alliance Inc which is valued at $6,524,463.Walgreens Boots Alliance Inc makes up approximately 1.25% of Calamos Wealth Management’s portfolio.
Other Hedge Funds, Including , Cumberland Partners Ltd reduced its stake in WBA by selling 15,253 shares or 3.51% in the most recent quarter. The Hedge Fund company now holds 419,012 shares of WBA which is valued at $33,495,819. Walgreens Boots Alliance Inc makes up approx 4.58% of Cumberland Partners Ltd’s portfolio.Shikiar Asset Management Inc reduced its stake in WBA by selling 28,325 shares or 41.25% in the most recent quarter. The Hedge Fund company now holds 40,345 shares of WBA which is valued at $3,282,066. Walgreens Boots Alliance Inc makes up approx 1.40% of Shikiar Asset Management Inc’s portfolio.Murphy Capital Management Inc reduced its stake in WBA by selling 550 shares or 2.62% in the most recent quarter. The Hedge Fund company now holds 20,450 shares of WBA which is valued at $1,687,330. Walgreens Boots Alliance Inc makes up approx 0.25% of Murphy Capital Management Inc’s portfolio.Raymond James Trust N.a. boosted its stake in WBA in the latest quarter, The investment management firm added 3,514 additional shares and now holds a total of 21,702 shares of Walgreens Boots Alliance Inc which is valued at $1,775,224. Walgreens Boots Alliance Inc makes up approx 0.15% of Raymond James Trust N.a.’s portfolio.
Walgreens Boots Alliance Inc closed down -0.21 points or -0.26% at $79.25 with 37,30,298 shares getting traded on Friday. Post opening the session at $79.49, the shares hit an intraday low of $78.8 and an intraday high of $79.565 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
On the company’s financial health, Walgreens Boots Alliance Inc reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Jul 6, 2016. Analyst had a consensus of $1.14. The company had revenue of $29498.00 million for the quarter, compared to analysts expectations of $29719.29 million. The company’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.02 EPS.
Many Wall Street Analysts have commented on Walgreens Boots Alliance Inc. Shares were Reiterated by FBR Capital on Jul 7, 2016 to “Mkt Perform” and Lowered the Price Target to $ 85 from a previous price target of $90 .Walgreens Boots Alliance Inc was Resumed by BofA/Merrill to “Buy” on Jun 7, 2016.
Walgreens Boots Alliance Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led health and wellbeing enterprise. It operates through three segments: Retail Pharmacy USA which consists of the Walgreens business including the operation of retail drugstores and convenient care clinics in addition to providing specialty pharmacy services; Retail Pharmacy International which consists of the Alliance Boots pharmacy-led health and beauty stores optical practices and related contract manufacturing operations and Pharmaceutical Wholesale which consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses. Its portfolio of retail and business brands includes Walgreens Duane Reade Boots and Alliance Healthcare as well as global health and beauty product brands including No7 Botanics and Soap & Glory. Walgreens Boots Alliance through its subsidiary Liz Earle Beauty Co. Ltd offers the Liz Earle skincare brand.